SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-24-069249
Filing Date
2024-08-14
Accepted
2024-08-14 18:28:05
Documents
1
Period of Report
2024-08-12

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4320
  Complete submission text file 0001213900-24-069249.txt   5876
Mailing Address C/O CITIUS PHARMACEUTICALS, INC. 11 COMMERCE DRIVE, 1ST FLOOR CRANFORD NJ 07016
Business Address
Czuczman Myron (Reporting) CIK: 0001817716 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41534 | Film No.: 241210041

Mailing Address 420 LEXINGTON AVE, SUITE 2446 NEW YORK NY 10017
Business Address 420 LEXINGTON AVE, SUITE 2446 NEW YORK NY 10017 (347) 627-0058
CITIUS ONCOLOGY, INC. (Issuer) CIK: 0001851484 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)